Russia to Distribute COVID-19 Vaccine in Seven LATAM Countries

(TELESUR) – Sixty-five percent of the 40 patients who took Avifavir during clinical trials tested negative for COVID-19 on the fourth day of use.

 

These seven Latin American countries will receive a batch of 150,000 units of Avifavir, while Bolivia’s company Sigma will receive the technology to manufacture the drug.

The donation is part of an agreement signed between the company Kromis, which belongs to the group JimRar that created the vaccine, and Sigma.

On May 29, Russia’s Health Ministry delivered a registration certificate for the drug Avifavir.

“During the first stage of clinical trials, it proved to be highly efficient,” Russia’s Health Ministry stated.

Sixty-five percent of the 40 patients who took Avifavir during clinical trials tested negative for COVID-19 on the fourth day of use. After ten days, 90 percent of the patients tested negative.

By News784

News784 posted this article. You can send press releases and news ideas to [email protected]